3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
INDUSTRY
4
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
8
Thoracic
4
Gastrointestinal
4
Other hematologic neoplasm
3
Lymphoid
3
Head & Neck
3
Genitourinary
3
Sarcoma
2
Gynecologic
2
CNS
2
Plasma cell
1
Other
1
Myeloid
1
Dermatologic
1
Classical hematology
1
Conditions
Multiple Myeloma
2121
Neoplasms, Plasma Cell
505
Lymphoma
354
Lymphoma, Non-Hodgkin
334
Hodgkin Disease
329
Leukemia, Lymphocytic, Chronic, B-Cell
307
Precursor Cell Lymphoblastic Leukemia-Lymphoma
299
Leukemia
290
Leukemia, Myeloid, Acute
270
Myelodysplastic Syndromes
263
Lymphoma, Mantle-Cell
228
Lymphoma, Follicular
224
Lymphoma, Large B-Cell, Diffuse
216
Lymphoma, B-Cell, Marginal Zone
206
Burkitt Lymphoma
201
Recurrence
188
Myeloproliferative Disorders
182
Lymphoma, Large-Cell, Immunoblastic
182
Immunoglobulin Light-chain Amyloidosis
162
Primary Myelofibrosis
153
Leukemia, Myeloid, Chronic-Phase
152
Leukemia, Myeloid, Accelerated Phase
143
Lymphoma, T-Cell, Cutaneous
140
Leukemia, Myelomonocytic, Chronic
133
Blast Crisis
131
Mycosis Fungoides
126
Sezary Syndrome
125
Congenital Abnormalities
122
Waldenstrom Macroglobulinemia
121
Leukemia, Hairy Cell
110
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypersensitivity
×
Plasma cell
×
Clear all
NCT05001386
2022-03-17
ESAAC
Hospices Civils de Lyon
Phase NA
Unknown
800 enrolled